VIPAR Antikörper (Middle Region)
Kurzübersicht für VIPAR Antikörper (Middle Region) (ABIN632204)
Target
Alle VIPAR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- VIPAR antibody was raised against the middle region of VIPAR
-
Aufreinigung
- Affinity purified
-
Immunogen
- VIPAR antibody was raised using the middle region of VIPAR corresponding to a region with amino acids VEDVDTKLNLATKFKCHDVVIDTYRDLKDRQQLLAYRSKVDKGSAEEEKI
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
VIPAR Blocking Peptide, (ABIN5616968), is also available for use as a blocking control in assays to test for specificity of this VIPAR antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of VIPAR antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- VIPAR (VPS33B Interacting Protein, Apical-Basolateral Polarity Regulator (VIPAR))
-
Andere Bezeichnung
- VIPAR
-
Hintergrund
- This protein is involved in the sorting of lysosomal proteins. Mutations in this gene are associated with ARCS2 (arthrogryposis, renal dysfunction, and cholestasis-2). Alternative splicing results in multiple transcript variants.
-
Molekulargewicht
- 57 kDa (MW of target protein)
Target
-